Throat cancer is a relatively common malignant tumor in the head and neck area. Some patients can achieve clinical cure, which generally means no local recurrence or distant metastasis for 5 years after the end of treatment. However, the specific treatment outcomes can vary significantly among individuals. Generally, early-stage throat cancer has better treatment outcomes and a higher 5-year survival rate. If it's in the middle to late stages, throat cancer tends to be more difficult to treat and the outcomes are poorer. Therefore, it's important to seek prompt treatment from an otolaryngologist after the onset of the disease, receive targeted treatment, and undergo regular follow-ups to monitor the efficacy of the treatment.